What changed in ALTERITY THERAPEUTICS LTD's 2024 10-K compared to 2023?

Across the narrative sections we track, ALTERITY THERAPEUTICS LTD (ATHE) added 0 paragraphs, removed 0, and edited 0 between the 2023 and 2024 10-K filings. The biggest movers are .

Where does this ATHE 10-K diff come from?

The source filings are ALTERITY THERAPEUTICS LTD's official 2023 and 2024 Form 6-K annual reports from SEC EDGAR. 10q10k.net parses each filing, aligns paragraphs by section (Item 1, 1A, 1C, 2, 3, 7, 7A), and highlights every added, removed and edited sentence side-by-side.

ALTERITY THERAPEUTICS LTDATHE決算レポート

Nasdaq · pharmaceutical industry

Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs.

What changed in ALTERITY THERAPEUTICS LTD's 6-K — 2023 vs 2024

No meaningful paragraph-level changes detected in the compared sections. Either the two filings are nearly identical or the sections did not parse.